Login / Signup

Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.

Gui-Fang ZhuYang-Wei XuJian LiHui-Lin NiuWen-Xia MaJia XuPei-Rong ZhouXia LiuDan-Li YeXiao-Rong LiuTao YanWei-Ke ZhaiZhi-Jun XuChun LiuLei WangHao WangJia-Mao LuoLi LiuXuan-Qi LiSuiqun GuoHui-Ping JiangPeng ShenHui-Kuan LinDi-Hua YuYan-Qing DingQing-Ling Zhang
Published in: Nature communications (2019)
Wilms tumor gene on the X chromosome (WTX) is a putative tumor suppressor gene in Wilms tumor, but its expression and functions in other tumors are unclear. Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in women and the second leading cause in men in the United States. We demonstrated that WTX frequently lost in CRC which was highly correlated with cell proliferation, tumor invasion and metastasis. Mechanistically, WTX loss disrupts the interaction between RhoGDIα and CDC42 by losing of the binding with RhoGDIα and triggers the activation of CDC42 and its downstream cascades, which promotes CRC development and liver metastasis. The aberrant upregulation of miR-20a/miR-106a were identified as the reason of WTX loss in CRC both in vivo and in vitro. These study defined the mechanism how miR-20a/miR-106a-mediated WTX loss regulates CRC progression and metastasis, and provided a potential therapeutic target for preventing CRC progression.
Keyphrases